![](/img/cover-not-exists.png)
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer
Mark Shilkrut, Gregory S. Merrick, P. William McLaughlin, Matthew H. Stenmark, Eyad Abu-Isa, Sean M. Vance, Howard M. Sandler, Felix Y. Feng, Daniel A. HamstraVolume:
aop
Year:
2012
Language:
english
Pages:
1
DOI:
10.1002/cncr.27784
File:
PDF, 716 KB
english, 2012